Novel Biomarkers: Utility in Patients with Acute Chest Pain and Relationship to Coronary Artery Disease on Coronary CT Angiography

Adefolakemi Babatunde; Asim Rizvi; Quynh A. Truong

doi:10.1007/s12410-014-9277-x

Novel Biomarkers: Utility in Patients with Acute Chest Pain and Relationship to Coronary Artery Disease on Coronary CT Angiography

Adefolakemi Babatunde, Asim Rizvi, Quynh A. Truong

Research output: Contribution to journal › Review article › peer-review

Abstract

Acute chest pain remains one of the most common patient presentations encountered in the emergency department. With the evolution of biomarkers and improvement in cardiac imaging there has been advancement in risk stratification of patients, but millions of dollars continue to be spent in the assessment of chest pain. Investigators have explored possible comparative alternatives to the traditional work up of chest pain. In this review, we will discuss the current state of biomarker use in the evaluation of acute chest pain. We will review established and emerging circulating biomarkers and their addition to cardiac CT for appropriate diagnosis of coronary artery disease.

Original language	English (US)
Article number	9277
Pages (from-to)	1-7
Number of pages	7
Journal	Current Cardiovascular Imaging Reports
Volume	7
Issue number	7
DOIs	https://doi.org/10.1007/s12410-014-9277-x
State	Published - Jun 2014
Externally published	Yes

Keywords

Biomarkers
Cardiac CT
Coronary artery disease

ASJC Scopus subject areas

Histology
Applied Microbiology and Biotechnology
Cell Biology

Access to Document

10.1007/s12410-014-9277-x

Cite this

@article{37fca41bc0fc4a42a333e43e53fa3cda,

title = "Novel Biomarkers: Utility in Patients with Acute Chest Pain and Relationship to Coronary Artery Disease on Coronary CT Angiography",

abstract = "Acute chest pain remains one of the most common patient presentations encountered in the emergency department. With the evolution of biomarkers and improvement in cardiac imaging there has been advancement in risk stratification of patients, but millions of dollars continue to be spent in the assessment of chest pain. Investigators have explored possible comparative alternatives to the traditional work up of chest pain. In this review, we will discuss the current state of biomarker use in the evaluation of acute chest pain. We will review established and emerging circulating biomarkers and their addition to cardiac CT for appropriate diagnosis of coronary artery disease.",

keywords = "Biomarkers, Cardiac CT, Coronary artery disease",

author = "Adefolakemi Babatunde and Asim Rizvi and Truong, {Quynh A.}",

note = "Funding Information: Acknowledgments Quynh A Truong receives grant support from NIH/NHLBI K23HL098370, L30HL093896, St. Jude Medical, American College of Radiology Imaging Network, and Duke Clinical Research Institute.",

year = "2014",

month = jun,

doi = "10.1007/s12410-014-9277-x",

language = "English (US)",

volume = "7",

pages = "1--7",

journal = "Current Cardiovascular Imaging Reports",

issn = "1941-9066",

publisher = "Current Medicine Group",

number = "7",

}

TY - JOUR

T1 - Novel Biomarkers

T2 - Utility in Patients with Acute Chest Pain and Relationship to Coronary Artery Disease on Coronary CT Angiography

AU - Babatunde, Adefolakemi

AU - Rizvi, Asim

AU - Truong, Quynh A.

N1 - Funding Information: Acknowledgments Quynh A Truong receives grant support from NIH/NHLBI K23HL098370, L30HL093896, St. Jude Medical, American College of Radiology Imaging Network, and Duke Clinical Research Institute.

PY - 2014/6

Y1 - 2014/6

N2 - Acute chest pain remains one of the most common patient presentations encountered in the emergency department. With the evolution of biomarkers and improvement in cardiac imaging there has been advancement in risk stratification of patients, but millions of dollars continue to be spent in the assessment of chest pain. Investigators have explored possible comparative alternatives to the traditional work up of chest pain. In this review, we will discuss the current state of biomarker use in the evaluation of acute chest pain. We will review established and emerging circulating biomarkers and their addition to cardiac CT for appropriate diagnosis of coronary artery disease.

AB - Acute chest pain remains one of the most common patient presentations encountered in the emergency department. With the evolution of biomarkers and improvement in cardiac imaging there has been advancement in risk stratification of patients, but millions of dollars continue to be spent in the assessment of chest pain. Investigators have explored possible comparative alternatives to the traditional work up of chest pain. In this review, we will discuss the current state of biomarker use in the evaluation of acute chest pain. We will review established and emerging circulating biomarkers and their addition to cardiac CT for appropriate diagnosis of coronary artery disease.

KW - Biomarkers

KW - Cardiac CT

KW - Coronary artery disease

UR - http://www.scopus.com/inward/record.url?scp=84903183691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903183691&partnerID=8YFLogxK

U2 - 10.1007/s12410-014-9277-x

DO - 10.1007/s12410-014-9277-x

M3 - Review article

C2 - 25750691

AN - SCOPUS:84903183691

SN - 1941-9066

VL - 7

SP - 1

EP - 7

JO - Current Cardiovascular Imaging Reports

JF - Current Cardiovascular Imaging Reports

IS - 7

M1 - 9277

ER -

Novel Biomarkers: Utility in Patients with Acute Chest Pain and Relationship to Coronary Artery Disease on Coronary CT Angiography

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this